Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTA) Invested Capital (2019 - 2025)

Historic Invested Capital for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to $283.0 million.

  • Strata Critical Medical's Invested Capital rose 2119.97% to $283.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $283.0 million, marking a year-over-year increase of 2119.97%. This contributed to the annual value of $221.9 million for FY2024, which is 527.61% down from last year.
  • As of Q3 2025, Strata Critical Medical's Invested Capital stood at $283.0 million, which was up 2119.97% from $223.1 million recorded in Q2 2025.
  • Over the past 5 years, Strata Critical Medical's Invested Capital peaked at $296.7 million during Q2 2021, and registered a low of $7.7 million during Q1 2021.
  • For the 5-year period, Strata Critical Medical's Invested Capital averaged around $247.0 million, with its median value being $262.9 million (2023).
  • As far as peak fluctuations go, Strata Critical Medical's Invested Capital skyrocketed by 572740.83% in 2021, and later tumbled by 1464.14% in 2023.
  • Over the past 5 years, Strata Critical Medical's Invested Capital (Quarter) stood at $291.4 million in 2021, then fell by 5.79% to $274.5 million in 2022, then dropped by 14.64% to $234.3 million in 2023, then fell by 5.28% to $221.9 million in 2024, then grew by 27.51% to $283.0 million in 2025.
  • Its last three reported values are $283.0 million in Q3 2025, $223.1 million for Q2 2025, and $219.7 million during Q1 2025.